22
Views
42
CrossRef citations to date
0
Altmetric
Review

Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agents

Pages 313-325 | Published online: 02 Mar 2005
 

Abstract

The discovery in the mid 1990s that melanin-concentrating hormone (MCH) is a strong appetite stimulant has led to a rapid increase in interest in this peptide. Significant evidence now exists establishing the key role that MCH plays in controlling food intake and energy homeostasis. Interest was further heightened by the discovery of two G-protein-coupled receptors (GPCRs) that were bound to, and activated by, MCH. Of these two receptors, only one, the MCH1 receptor, is expressed in rodents and as a result most of the efforts to identify MCH antagonists have focused on this receptor. Significant medicinal chemistry programmes from a number of companies have produced a variety of drug-like, low molecular weight MCH antagonists, a number of which have shown highly promising efficacy in a variety of animal models of food intake and body weight.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.